Research output per year
Research output per year
- 1 - 50 out of 86 results
Search results
-
2025
Evaluating the Quality of Real-World Data on Adherence to Oral Endocrine Therapy in Breast Cancer Patients : How Real Is Real-World Data?
Navarro-Sabaté, A., Font, R., Espinas, J. A., Solà, J., Martinez, F., Gil-Gil, M., Viñas, G., Tibau Martorell, A., Borrell, M., Segui Palmer, M. A., Margelí, M., Servitja, S., Pérez Segura, C., Domènech, M. F., Nava, M. A., Marin, M. T., González, S. & Borras, J. M., 9 Jan 2025, In: Cancers. 17, 2, 11 p., 200.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
2024
Assessing the Prognostic Value of Cytoplasmic and Stromal Caveolin-1 in Early Triple-Negative Breast Cancer Undergoing Neoadjuvant Chemotherapy
Teruel, I., Castellà, E., Recalde, S., Viñas, G., Petit, A., Trigueros, M., Martínez-Balibrea, E., Felip, E., Sirvén, M. B., Bernat-Peguera, A., Cirauqui, B., Quiroga, V., Díez, A. F., Pous, A., López, A., Boronat, L., Soler, G., Recuero, J., Romeo, M. & Guillén, P. & 4 others, , 14 Nov 2024, In: International journal of molecular sciences. 25, 22, 12 p., 12241.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Deciphering HER2-low breast cancer (BC): insights from real-world data in early stage breast cancer
Pous, A., Bernat-Peguera, A., López-Paradís, A., Cirauqui, B., Quiroga, V., Teruel, I., Felip, E., Ferrando-Díez, A., Bergamino, M., Boronat, L., Romeo, M., Soler, G., Mariño, C., Rodríguez-Martínez, P., Pons, L., Ballana, E., Martinez-Cardús, A. & Margelí, M., Jan 2024, In: Therapeutic Advances in Medical Oncology. 16, 15 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Citation (Scopus) -
Elderly patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with CDK4/6 inhibitors in a multicentre cohort
Pla, H., Felip, E., Obadia, V., Pernas, S., Viñas, G., Margelí, M., Fort-Culillas, R., Del Barco, S., Sabaté, N., Fort, E., Lezcano, C., Cirauqui, B., Quiroga, V., Stradella, A., Gil Gil, M., Esteve, A. & Recalde, S., 22 Mar 2024, In: Clinical and Translational Oncology. 26, 7, p. 1748-1758 11 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access4 Citations (Scopus) -
Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response
Brasó-Maristany, F., Ferrero-Cafiero, J. M., Falato, C., Martínez-Sáez, O., Cejalvo, J. M., Margelí, M., Tolosa, P., Salvador-Bofill, F. J., Cruz, J., González-Farré, B., Sanfeliu, E., Òdena, A., Serra, V., Pardo, F., Luna Barrera, A. M., Arumi, M., Guerra, J. A., Villacampa, G., Sánchez-Bayona, R. & Ciruelos, E. & 15 others, , 11 Jul 2024, In: Nature communications. 15, 1, 13 p., 5826.Research output: Contribution to journal › Article › Research › peer-review
Open Access7 Citations (Scopus) -
2023
CCNE1 and PLK1 Mediate Resistance to Palbociclib in HR+/HER2- Metastatic Breast Cancer
Guerrero Zotano, A., Belli, S., Zielinski, C. C., Gil-Gil, M., Fernández-Serra, A., Ruiz-Borrego, M., Ciruelos Gil, E. M., Pascual, J., Muñoz-Mateu, M., Bermejo, B., Margeli Vila, M., Antón, A., Murillo, L., Nissenbaum, B., Yuan, L. Y., Herranz, J., Fernández-García , D., Caballero , R., López-Guerrero , J. & Bianci, R. & 3 others, , 14 Apr 2023, In: Clinical Cancer Research. 29, 8, p. 1557-1568 12 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access26 Citations (Scopus) -
Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer
Prat, A., Brasó-Maristany, F., Martínez-Sáez, O., Sanfeliu, E., Xia, Y., Bellet, M., Galván, P., Martínez, D., Pascual, T., Marín-Aguilera, M., Rodríguez, A., Chic, N., Adamo, B., Paré, L., Vidal, M., Margelí, M., Ballana, E., Gómez-Rey, M., Oliveira, M. & Felip, E. & 12 others, , 1 Mar 2023, (E-pub ahead of print) In: Nature communications. 14, 16 p., 1157.Research output: Contribution to journal › Article › Research › peer-review
Open Access30 Citations (Scopus) -
Correction to: SEOM–GEICAM–SOLTI clinical guidelines in advanced breast cancer (2022) (Clinical and Translational Oncology, (2023), 25, 9, (2665-2678), 10.1007/s12094-023-03203-8)
Garcia-Saenz, J. A., Blancas, I., Echavarria, I., Hinojo, C., Margeli, M., Moreno, F., Pernas, S., Ramon y Cajal, T., Ribelles, N. & Bellet, M., Sept 2023, In: Clinical and Translational Oncology. 25, 9, p. 2759-2759 1 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
HOPE (SOLTI-1903) breast cancer study: real-world, patient-centric, clinical practice study to assess the impact of genomic data on next treatment decision-choice in patients with locally advanced or metastatic breast cancer
Olivera-Salguero, R., Seguí, E., Cejalvo, J. M., Oliveira, M., Tolosa, P., Vidal, M., Malumbres, M., Gavilá, J., Saura, C., Pernas, S., López, R., Margeli Vila, M., Balmaña, J., M., M., Blancas, I., Boni, V., Ciruelos, E. M., Galve, E., Perelló, A. & Sánchez-Bayona, R. & 14 others, , 28 Apr 2023, In: Frontiers in Oncology. 13, 9 p., 1151496.Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Citation (Scopus) -
Patritumab deruxtecan in untreated hormone receptor-positive/HER2-negative early breast cancer: final results from part A of the window-of-opportunity SOLTI TOT-HER3 pre-operative study
Oliveira, M., Falato, C., Cejalvo, J. M., Vila, M. M., Tolosa, P., Salvador-Bofill, F. J., Cruz, J., Arumi, M., Luna, A. M., Guerra, J. A., Vidal, M., Martínez-Sáez, O., Paré, L., González-Farré, B., Sanfeliu, E., Ciruelos, E., Espinosa-Bravo, M., Pernas, S., Izarzugaza, Y. & Esker, S. & 8 others, , Aug 2023, In: Annals of Oncology. 34, 8, p. 670-680 11 p.Research output: Contribution to journal › Article › Research › peer-review
27 Citations (Scopus) -
Pre- and Post-Neoadjuvant Clinicopathological Parameters Can Help in the Prognosis and the Prediction of Response in HER2+ and Triple Negative Breast Cancer
Pons, L., Hernández, L., Urbizu, A., Osorio, P., Rodríguez-Martínez, P., Castella, E., Muñoz, A., Sanz, C., Arnaldo, L., Felip, E., Quiroga, V., Tapia, G., Margelí, M. & Fernandez, P. L., 6 Jun 2023, In: Cancers. 15, 12, 19 p., 3068.Research output: Contribution to journal › Article › Research › peer-review
Open Access4 Citations (Scopus) -
SAMHD1 expression is a surrogate marker of immune infiltration and determines prognosis after neoadjuvant chemotherapy in early breast cancer
Gutierrez- Chamorro, L., Felip Falgas, E., Castella Fernández, E. M., Quiroga García, V., Ezeonwumelu, I. J., Angelats, L., Esteve, A., Pérez-Roca, L., Martinez-Cardus, A., Fernandez Ruiz, P. L., Ferrando-Díez, A., Pous, A., Sirven, M. B., Cirauqui Cirauqui, B., Romeo, M., Teruel Garcia, I., Mesia, R., Clotet, B., Riveiro-Munõz, E. & Margeli Vila, M. & 1 others, , 4 Sept 2023, In: Cellullar Oncology. 20 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access4 Citations (Scopus) -
SAMHD1 expression modulates innate immune activation and correlates with ovarian cancer prognosis
Gutiérrez-Chamorro, L., Felip, E., Bernat-Peguera, A., Ezeonwumelu, I. J., Teruel, I., Martínez-Cardús, A., Clotet, B., Riveira-Muñoz, E., Romeo, M., Margelí, M. & Ballana, E., 9 Feb 2023, (E-pub ahead of print) In: Frontiers in immunology. 14, 10 p., 1112761.Research output: Contribution to journal › Article › Research › peer-review
Open Access3 Citations (Web of Science) -
SEOM–GEICAM–SOLTI clinical guidelines in advanced breast cancer (2022)
Garcia-Saenz, J. A., Blancas, I., Echavarria, I., Hinojo, C., Margeli, M., Moreno, F., Pernas, S., Ramon y Cajal, T., Ribelles, N. & Bellet, M., Sept 2023, In: Clinical and Translational Oncology. 25, 9, p. 2665-2678 14 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access16 Citations (Scopus) -
2022
Conventional and digital Ki67 evaluation and their correlation with molecular prognosis and morphological parameters in luminal breast cancer
Pons, L., Hernández-León, L., Altaleb, A., Ussene, E., Iglesias, R., Castillo, A., Rodríguez-Martínez, P., Castella, E., Quiroga, V., Felip, E., Cirauqui, B., Margelí, M. & Fernández, P. L., 17 May 2022, In: SCIENTIFIC REPORTS. 12, 1, p. 8176Research output: Contribution to journal › Article › Research › peer-review
Open Access7 Citations (Scopus) -
Efficacy of CT-P6 (trastuzumab biosimilar) versus reference trastuzumab in combination with pertuzumab in HER2-positive early-stage breast cancer: Preclinical and real-life clinical data
Bernat-Peguera, A., Trigueros, M., Ferrando-Díez, A., Ibáñez, C., Bystrup, S., Martínez-Cardús, A., Margelí, M. & Martínez-Balibrea, E., Apr 2022, In: Breast. 62, p. 1-9 9 p.Research output: Contribution to journal › Article › Research › peer-review
4 Citations (Scopus) -
Modulation of DNA Damage Response by SAM and HD Domain Containing Deoxynucleoside Triphosphate Triphosphohydrolase (SAMHD1) Determines Prognosis and Treatment Efficacy in Different Solid Tumor Types
Romeo, M., Gómez, M., Riveira-Muñoz, E., Felip, E., Perez-Roca, L., Margeli Vila, M., Clotet, B., Ballana, E., Mesía, R., Martinez-Cardus, A., Fernandez Ruiz, P. L., Layos, L., Garcia-Vidal, E., Gutiérrez-Chamorro, L. & Moran Bueno, T., 27 Jan 2022, In: Cancers. 14, 3, 20 p., 641.Research output: Contribution to journal › Article › Research › peer-review
Open Access11 Citations (Scopus) -
Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study
Martín, M., Zielinski, C., Ruiz-Borrego, M., Carrasco, E., Ciruelos, E. M., Muñoz, M., Bermejo, B., Margelí, M., Csöszi, T., Antón, A., Turner, N., Casas, M. I., Morales, S., Alba, E., Calvo, L., de la Haba-Rodríguez, J., Ramos, M., Murillo, L., Santaballa, A. & Alonso-Romero, J. L. & 6 others, , Jun 2022, In: European Journal of Cancer. 168, p. 12-24 13 p.Research output: Contribution to journal › Article › Research › peer-review
18 Citations (Scopus) -
Randomized phase II study of fulvestrant plus palbociclib or placebo in endocrine-sensitive, hormone receptor-positive/HER2-advanced breast cancer: Geicam/2014-12 (flipper)
Albanell, J., Martínez, M. T., Ramos, M., O'Connor, M., de la Cruz-Merino, L., Santaballa, A., Martínez-Jañez, N., Moreno, F., Fernández, I., Alarcón, J., Virizuela, J. A., de la Haba-Rodríguez, J., Sánchez-Rovira, P., González-Cortijo, L., Margelí, M., Sánchez-Muñoz, A., Antón, A., Casas, M., Bezares, S. & Rojo, F., Jan 2022, In: European Journal of Cancer. 161, p. 26-37 12 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access32 Citations (Scopus) -
Role of ctDNA in Breast Cancer
Sant, M., Bernat-Peguera, A., Felip, E. & Vila, M. M., Jan 2022, In: Cancers. 14, 2, p. 310 14 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access64 Citations (Scopus) -
Targeted Therapeutic Options and Future Perspectives for HER2-Positive Breast Cancer
Díez, A. F., Felip, E., Pous, A., Sirven, M. B. & Vila, M. M., Jul 2022, In: Cancers. 14, 14, p. 3305Research output: Contribution to journal › Article › Research › peer-review
Open Access23 Citations (Scopus) -
2021
Advantages of preoperative localization and surgical resection of metastatic axillary lymph nodes using magnetic seeds after neoadjuvant chemotherapy in breast cancer
Mariscal Martínez, A., Vives Roselló, I., Salazar Gómez, A., Catanese, A., Pérez Molina, M., Solà Suarez, M., Pascual Miguel, I., Blay Aulina, L., Ríos Gozálvez, C., Julián Ibáñez, J. F., Rodríguez Martínez, P., Martínez Román, S., Margelí Vila, M. & Luna Tomás, M. A., Mar 2021, In: Surgical Oncology. 36, p. 28-33 6 p.Research output: Contribution to journal › Article › Research › peer-review
34 Citations (Scopus) -
Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysis
Hartkopf, A. D., Brucker, S. Y., Taran, F.-A., Harbeck, N., von Au, A., Naume, B., Pierga, J.-Y., Hoffmann, O., Beckmann, M. W., Rydén, L., Fehm, T., Aft, R., Solà, M., Walter, V., Rack, B., Schuetz, F., Borgen, E., Ta, M.-H., Bittner, A.-K. & Fasching, P. A. & 17 others, , Sept 2021, In: European Journal of Cancer. 154, p. 128-137 10 p.Research output: Contribution to journal › Article › Research › peer-review
38 Citations (Scopus) -
Health-related quality of life with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive metastatic breast cancer: Patient-reported outcomes in the PEARL study
Kahan, Z., Gil-Gil, M., Ruiz-Borrego, M., Carrasco, E., Ciruelos, E., Muñoz, M., Bermejo, B., Margeli, M., Antón, A., Casas, M., Csöszi, T., Murillo, L., Morales, S., Calvo, L., Lang, I., Alba, E., de la Haba-Rodriguez, J., Ramos, M., López, I. Á. & Gal-Yam, E. & 9 others, , Oct 2021, In: European Journal of Cancer. 156, p. 70-82 13 p.Research output: Contribution to journal › Article › Research › peer-review
23 Citations (Scopus) -
Occult triple negative male breast cancer. The usefulness of molecular platforms. A case report.
Angelats, L., Estival-Gonzalez, A., Martinez-Cardus, A., Musulen Palet, E. & Margeli Vila, M., 15 Dec 2021, In: Current Problems in Cancer.Research output: Contribution to journal › Article › Research › peer-review
2 Citations (Scopus) -
Solti-1502 aRIANNA: Targeting PAM50 HER2-enriched intrinsic subtype with enzalutamide in hormone receptor-positive/HER2-negative metastatic breast cancer
Oliveira, M., Pernas, S., Margeli, M., Blanch, S., Adamo, B., Salvador Bofill, J., Moreno, D., Gonzalez-Farre, X., Rios, J., Perou, C. M., Prat, A., Pascual, T., Ferrero-Cafiero, J. M., Villagrasa, P. & Manso, L., 15 Feb 2021, In: Cancer Research. 81, 4_Supplement, p. OT-09-08.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast Cancer
Pascual, T., Oliveira, M., Ciruelos, E., Bellet Ezquerra, M., Saura, C., Gavilá, J., Pernas, S., Muñoz, M., Vidal, M. J., Margelí Vila, M., Cejalvo, J. M., González-Farré, B., Espinosa-Bravo, M., Cruz, J., Salvador-Bofill, F. J., Guerra, J. A., Luna Barrera, A. M., Arumi de Dios, M., Esker, S. & Fan, P.-D. & 6 others, , 23 Apr 2021, In: Frontiers in Oncology. 11, 9 p., 638482.Research output: Contribution to journal › Article › Research › peer-review
Open Access24 Citations (Scopus) -
2020
301P Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for alpelisib (ALP)-induced hyperglycemia: A report of 6 cases from SOLAR-1
Lu, Y.-S., Chiu, J., Airoldi, M., Vila, M. M., Lorenzo, J. P., Ghaznawi, F., Gaudenzi, F., Ridolfi, A., Lorenzo, I. & Borrego, M. R., Sept 2020, In: Annals of Oncology. 31, Supl. 4, p. S363-S363 1 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Breast Cancer Patient with Li-Fraumeni Syndrome: A Case Report Highlighting the Importance of Multidisciplinary Management
Cirauqui, B., Morán, T., Estival, A., Quiroga, V., Etxaniz, O., Balana, C., Navarro, M., Villà, S., Ballester, R. & Margelí, M., Jan 2020, In: Case Reports in Oncology. 13, 1, p. 130-138 9 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Citation (Scopus) -
Erratum : Castellví, M. et al. Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy. Cancers 2020, 12, 713
Felip, E., Ezeonwumelu, I. J., Badia, R., García Vidal, E., Pujantell, M., Gutiérrez-Chamorro, L., Teruel, I., Martínez Cardús, A., Clotet Sala, B., Riveira-Muñoz, E., Margelí, M., Este, J. & Ballana, E., 2020, In: Cancers. 12Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Influencia de la pandemia por enfermedad por coronavirus 2019 en el manejo del cáncer de mama
Translated title of the contribution :Influence of the 2019-novel coronavirus pandemic on the management of breast cancer Research output: Contribution to journal › Article › Research › peer-review
4 Citations (Scopus) -
New Drugs, Old Toxicities: Pneumonitis Related to Palbociclib - A Case Report
Felip, E., Llobera, L., Perez-Mañá, C., Quintela, D., Guasch, I., Margelí, M., Teruel, I., Cirauqui, B., Centeno, C., Romeo, M., Ballana, E. & Quiroga, V., Oct 2020, In: Breast Care. 15, 5, p. 548-552 5 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access8 Citations (Scopus) -
Pharmacological modulation of SAMHD1 activity by CDK4/6 inhibitors improves anticancer therapy
Castellví, M., Felip, E., Ezeonwumelu, I. J., Badia, R., García Vidal, E., Pujantell, M., Gutiérrez-Chamorro, L., Teruel, I., Martínez Cardús, A., Clotet Sala, B., Riveira Muñoz, E., Margelí, M. & Ballana, E., 2020, In: Cancers. 12, 3Research output: Contribution to journal › Article › Research › peer-review
Open Access17 Citations (Scopus) -
Psychosocial aspects and life project disruption in young women diagnosed with metastatic hormone-sensitive HER2-negative breast cancer
Margeli Vila, M., Del Barco Berron, S., Gil, M., Ochoa Arnedo, C. & Villanueva vazquez, R., Oct 2020, In: Breast. 53, p. 44-50 7 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access13 Citations (Scopus) -
2019
A Single-Center Retrospective Study of Patients with Double Primary Cancers: Breast Cancer and EGFR-Mutant Non-Small Cell Lung Cancer: Breast Cancer and EGFR-Mutant Non-Small Cell Lung Cancer
Moran, T., Quiroga, V., Cirauqui, B., Vila, L., Gil-Moreno, M., Carcereny, E., Margeli, M., Muñoz-Marmol, A., Mate, J. L., Velarde, J. M., Molina, M. A. & Rosell, R., Mar 2019, In: Oncology Research and Treatment. 42, 3, p. 107-114 8 p.Research output: Contribution to journal › Article › Research › peer-review
5 Citations (Scopus) -
BOMET-QoL-10 questionnaire for breast cancer patients with bone metastasis: the prospective MABOMET GEICAM study
Barnadas, A., Muñoz, M., Margelí, M., Chacón, J. I., Cassinello, J., Antolin, S., Adrover, E., Ramos, M., Carrasco, E., Jimeno, M. A., Ojeda, B., González, X., González, S., Constenla, M., Florián, J., Miguel, A., Llombart, A., Lluch, A., Ruiz-Borrego, M. & Colomer, R. & 1 others, , 21 Dec 2019, In: Journal of Patient-Reported Outcomes. 3, 1, 10 p., 72.Research output: Contribution to journal › Article › Research › peer-review
Open Access4 Citations (Scopus) -
Changes in dietary intake, plasma carotenoids and erythrocyte membrane fatty acids in breast cancer survivors after a lifestyle intervention: results from a single-arm trial
Buckland, G., Travier, N., Arribas, L., Del Barco, S., Pernas, S., Zamora, E., Bellet, M., Cirauqui, B., Margelí, M., Muñoz, M., Tusquets, I., Arcusa, A., Javierre, C., Moreno, F., Valverde, Y., Jansen, E., Chajès, V., Castro-Espin, C. & Agudo, A., Aug 2019, In: Journal of Human Nutrition and Dietetics. 32, 4, p. 468-479 12 p.Research output: Contribution to journal › Article › Research › peer-review
10 Citations (Scopus) -
Real-world data on T-DM1 efficacy - results of a single-center retrospective study of HER2-positive breast cancer patients
Hardy-Werbin, M., Quiroga, V., Cirauqui, B., Romeo, M., Felip, E., Teruel, I., Garcia, J. J., Erasun, C., España, S., Cucurull, M., Montprade, E., Pardo, J. C., Carballo, D., Velarde, J. M. & Margeli, M., 4 Sept 2019, In: SCIENTIFIC REPORTS. 9, 1, p. 12760Research output: Contribution to journal › Article › Research › peer-review
19 Citations (Scopus) -
Real-world data on the efficacy and safety of weekly oral vinorelbine in breast cancer patients previously treated with anthracycline or taxane-based regimens
Blancas, I., Aguirre, E., Morales, S., Gonzálvez, M. L., Servitja, S., Díaz, N., Del Barco, S., Barnadas, A., Margelí, M., García Carbonero, I. & Llombart, A., Apr 2019, In: Clinical and Translational Oncology. 21, 4, p. 459-466 8 p.Research output: Contribution to journal › Article › Research › peer-review
9 Citations (Scopus) -
SEOM clinical guidelines in early stage breast cancer (2018)
Ayala de la Peña, F., Andrés, R., Garcia-Sáenz, J. A., Manso, L., Margelí, M., Dalmau, E., Pernas, S., Prat, A., Servitja, S. & Ciruelos, E., Jan 2019, In: Clinical and Translational Oncology. 21, 1, p. 18-30 13 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access57 Citations (Scopus) -
2018
Changes in metabolic risk, insulin resistance, leptin and adiponectin following a lifestyle intervention in overweight and obese breast cancer survivors
Travier, N., Buckland, G., Vendrell, J. J., Fernandez-Veledo, S., Peiró, I., Del Barco, S., Pernas, S., Zamora, E., Bellet, M., Margeli, M., Cirauqui, B., Muñoz, M., Tusquets, I., Arcusa, A., Javierre, C., Moreno, F., Rodriguez, A. & Agudo, A., Jul 2018, In: European Journal of Cancer Care. 27, 4, p. e12861Research output: Contribution to journal › Article › Research › peer-review
24 Citations (Scopus) -
Identification of oestrogen, progesterone receptor and human epidermal growth factor receptor 2 expression in mediastinal metastases of breast cancer obtained by endobronchial ultrasound-guided transbronchial needle aspiration
Serra, P., Sanz-Santos, J., Castellà, E., Cirauqui, B., Andreo, F., Llatjós, M., Avila, M., Margelí, M., Serrano, L., Centeno, C., Quiroga, V., Torky, M. & Ruiz-Manzano, J., 1 Feb 2018, In: Cytopathology. 29, 1, p. 35-40Research output: Contribution to journal › Article › Research › peer-review
2 Citations (Scopus) -
2017
Development of a Risk Prediction Score for Occult Cancer in Patients With VTE
RIETE Investigators, Mar 2017, In: Chest. 151, 3, p. 564-571 8 p.Research output: Contribution to journal › Article › Research › peer-review
61 Citations (Scopus) -
HIP1 expression predicts outcome in breast cancer patients treated with neoadjuvant chemotherapy
Margeli, M., Quiroga, V., Tapia, G., Castella, E., Sola, M., Morgades, M., Rosell, R., Barnadas, A. & Cirauqui, B., 1 Jan 2017, In: Cancer Treatment and Research Communications. 11, p. 21-26Research output: Contribution to journal › Article › Research › peer-review
1 Citation (Scopus) -
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
ExteNET Study Group, Dec 2017, In: The Lancet Oncology. 18, 12, p. 1688-1700 13 p.Research output: Contribution to journal › Article › Research › peer-review
513 Citations (Scopus) -
Prognostic Significance of Venous Thromboembolic Events in Disseminated Germ Cell Cancer Patients
Gonzalez-Billalabeitia, E., Castellano, D., Sobrevilla, N., Guma, J., Hervas, D., Luengo, M. I., Aparicio, J., Sanchez-Muñoz, A., Mellado, B., Saenz, A., Valverde, C., Fernandez, A., Margeli, M., Duran, I., Fernandez, S., Sastre, J., Ros, S., Maroto, P., Manneh, R. & Cerezuela, P. & 6 others, , Jan 2017, In: Journal of the National Cancer Institute. 109, 4Research output: Contribution to journal › Article › Research › peer-review
11 Citations (Scopus) -
2016
DNA repair pathways to regulate response to chemoradiotherapy in patients with locally advanced head and neck cancer
Cirauqui, B., Margelí, M., Quiroga, V., Quer, A., Karachaliou, N., Chaib, I., Ramírez, J. L., Muñoz, A., Pollán, C., Planas, I., Drozdowsky, A. & Rosell, R., 1 Oct 2016, In: Tumor Biology. 37, 10, p. 13435-13443Research output: Contribution to journal › Article › Research › peer-review
10 Citations (Scopus) -
High Proliferation Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Early Breast Cancer
Alba, E., Lluch, A., Ribelles, N., Anton-Torres, A., Sanchez-Rovira, P., Albanell, J., Calvo, L., García-Asenjo, J. A. L., Palacios, J., Chacon, J. I., Ruiz, A., De la Haba-Rodriguez, J., Segui-Palmer, M. A., Cirauqui, B., Margeli, M., Plazaola, A., Barnadas, A., Casas, M., Caballero, R. & Carrasco, E. & 1 others, , Jun 2016, In: Oncologist. 21, 6, p. 778Research output: Contribution to journal › Article › Research › peer-review
-
Use of denosumab in a dialysis patient with bone metastases from breast cancer and hepatorenal polycystic disease: a case report
Quiroga García, V., Cirauqui Cirauqui, B., Tobey Robaina, L., López Sisamon, D., Hardy-Werbin, M., Blanca, A. B. & Margelí Vila, M., Jun 2016, In: Anti-Cancer Drugs. 27, 5, p. 464-9 6 p.Research output: Contribution to journal › Article › Research › peer-review
1 Citation (Scopus) -
2015
Epirubicin plus cyclophosphamide followed by docetaxel versus epirubicin plus docetaxel followed by capecitabine as adjuvant therapy for node-positive early breast cancer: Results from the GEICAM/2003-10 study
Martín, M., Simón, A. R., Borrego, M. R., Ribelles, N., Rodríguez-Lescure, Á., Muñoz-Mateu, M., González, S., Vila, M. M., Barnadas, A., Ramos, M., Del Barco Berron, S., Jara, C., Calvo, L., Martínez-Jáñez, N., Fernández, C. M., Rodríguez, C. A., De Dueñas, E. M., Andrés, R., Plazaola, A. & De La Haba-Rodríguez, J. & 10 others, , 10 Nov 2015, In: Journal of Clinical Oncology. 33, 32, p. 3788-3795Research output: Contribution to journal › Article › Research › peer-review
64 Citations (Scopus)